← Back to Search
Comparison Of Quantum Dot Biodistribution With A Blood-flow-limited Physiologically Based Pharmacokinetic Model.
H. A. Lee, T. Leavens, S. Mason, N. Monteiro-Riviere, J. Riviere
Published 2009 · Materials Science, Medicine
Save to my Library
Download via 🐼 PaperPanda Download via oaDOI Download via OAB Download via LibKey Download via Google Google ScholarAnalyze on Scholarcy Visualize in Litmaps
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
A physiologically based pharmacokinetic model with partition coefficients estimated from quantum dot (QD) 705 biodistribution was compared with the biodistribution of other QDs in mice and rats to determine the model's predictive ability across QD types, species, and exposure routes. The model predicted the experimentally observed persistence of QDs in tissues but not early time profiles or different QD biodistribution. Therefore, more complex models will be needed to better predict QD biodistribution in vivo.
This paper is referenced by
The Current Landscape of Novel Formulations and the Role of Mathematical Modeling in Their Development
Nicolas Cottura (2020)
Fast processes of nanoparticle blood clearance: Comprehensive study.
I. Zelepukin (2020)
Population pharmacokinetic modelling of indium-based quantum dot nanoparticles: preclinical in vivo studies
E. Yaghini (2020)
Meta-Analysis of Nanoparticle Delivery to Tumors Using a Physiologically Based Pharmacokinetic Modeling and Simulation Approach
Yi-Hsien Cheng (2020)
Current Approaches and Techniques in Physiologically Based Pharmacokinetic (PBPK) Modelling of Nanomaterials
W. Utembe (2020)
A history and recent efforts of selected physiologically based pharmacokinetic modeling topics
Zhoumeng Lin (2020)
dendPoint: a web resource for dendrimer pharmacokinetics investigation and prediction
L. M. Kaminskas (2019)
Endocytosis mechanism in physiologically-based pharmacokinetic modeling of nanoparticles.
Linjing Deng (2019)
Research tools for extrapolating the disposition and pharmacokinetics of nanomaterials from preclinical animals to humans
M. Valic (2019)
Directions in QPPR development to complement the predictive models used in risk assessment of nanomaterials
J. Quik (2018)
Modeling gold nanoparticle biodistribution after arterial infusion into perfused tissue: effects of surface coating, size and protein corona
J. Riviere (2018)
Physiologically based pharmacokinetic modeling of nanoceria systemic distribution in rats suggests dose- and route-dependent biokinetics
Ulrika Carlander (2018)
Biological and environmental surface interactions of nanomaterials: characterization, modeling, and prediction.
R. Chen (2017)
Etude toxicogénomique de nanovecteurs de silice mésoporeuse : relation entre décoration et toxicité
C. Pisani (2017)
Biocorona formation on gold nanoparticles modulates human proximal tubule kidney cell uptake, cytotoxicity and gene expression.
M. T. Ortega (2017)
Physiologically based pharmacokinetic modeling of nanoparticles in rodents
X. Li (2017)
Building the design, translation and development principles of polymeric nanomedicines using the case of clinically advanced poly(lactide(glycolide))-poly(ethylene glycol) nanotechnology as a model: An industrial viewpoint.
H. R. Lakkireddy (2016)
Physiologically Based Pharmacokinetic Model for Long-Circulating Inorganic Nanoparticles.
X. Liang (2016)
Physiologically Based Pharmacokinetic (PBPK) Modeling of Pharmaceutical Nanoparticles
Min Li (2016)
Computational Predictive Models for Nanomedicine
M. Siccardi (2016)
A physiologically based pharmacokinetic model for polyethylene glycol-coated gold nanoparticles of different sizes in adult mice
Z. Lin (2016)
Physiologically based modelling of nanoparticle biodistribution and biokinetics
Ulrika Carlander (2016)
In vivo biodistribution and physiologically based pharmacokinetic modeling of inhaled fresh and aged cerium oxide nanoparticles in rats
Dingsheng Li (2016)
Toward a general physiologically-based pharmacokinetic model for intravenously injected nanoparticles
Ulrika Carlander (2016)
Frameworks and tools for risk assessment of manufactured nanomaterials.
D. Hristozov (2016)
Physiologically Based Pharmacokinetic (PBPK) Model for Biodistribution of Radiolabeled Peptides in Patients with Neuroendocrine Tumours
Radovan Gospavić (2016)
Biodegradable Nanoparticles and Their In Vivo Fate
A. Kumari (2016)
A computational framework for interspecies pharmacokinetics, exposure and toxicity assessment of gold nanoparticles.
Z. Lin (2016)
Computational modeling of nanoparticle distribution and toxicity in biological systems
Dwaipayan Mukherjee (2015)
A Physiologically Based Pharmacokinetic Model Study of the Biological Fate, Transport and Behavior of Engineered Nanoparticles
Dingsheng Li (2015)
Biophysical, biopharmaceutical and toxicological significance of biomedical nanoparticles
S. Aula (2015)
Pharmacokinetics of metallic nanoparticles.
Zhoumeng Lin (2015)See more